SteelPeak Wealth’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$50.5K Hold
69,000
﹤0.01% 495
2025
Q1
$55.7K Hold
69,000
﹤0.01% 475
2024
Q4
$95.2K Hold
69,000
﹤0.01% 465
2024
Q3
$71.8K Hold
69,000
﹤0.01% 446
2024
Q2
$119K Hold
69,000
0.01% 437
2024
Q1
$165K Hold
69,000
0.01% 410
2023
Q4
$230K Buy
69,000
+15,000
+28% +$50K 0.01% 354
2023
Q3
$202K Buy
54,000
+12,000
+29% +$44.9K 0.01% 371
2023
Q2
$179K Buy
42,000
+21,000
+100% +$89.7K 0.01% 375
2023
Q1
$144K Buy
21,000
+5,000
+31% +$34.2K 0.01% 343
2022
Q4
$127K Buy
+16,000
New +$127K 0.01% 376